AMAL vs IGIC

AMAL's Piotroski F-Score of 4/9 indicates a weak financial health profile, signaling potential operational inefficiencies or instability despite solid profitability metrics. The absence of an Altman Z-Score raises concern about default risk, especially given the lack of available leverage and liquidity data. While the stock trades below its intrinsic value of $80.65 and Graham Number of $45.21, suggesting undervaluation, the current price of $38.10 is significantly below both benchmarks, implying either deep value or market skepticism. Strong earnings growth (11.1% YoY) and consistent beat rates (3/4 in last 4 quarters) support future potential, but technical trends and insider selling undermine near-term momentum.

IGIC presents a stark contrast between deep value and deteriorating financial health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($33.18) and Intrinsic Value ($85.26) with a low P/E of 8.94, the underlying fundamentals are concerning. Revenue is trending downward both YoY (-6.50%) and Q/Q (-15.52%), suggesting a struggle for top-line growth despite positive earnings growth. The combination of a bearish technical trend (10/100) and poor liquidity ratios offsets the attractive valuation metrics.